Alcohol Use Linked to Increased Cancer Risk, U.S. Surgeon General Warns
Five women out of every 100 that drink more than two drinks per day will develop breast cancer, U.S. health officials warn.
Five women out of every 100 that drink more than two drinks per day will develop breast cancer, U.S. health officials warn.
All four plaintiffs are breast cancer survivors who say their BioZorb tissue marker implants failed to properly absorb into their bodies as advertised.
Doctors are being urged not to implant recalled BioZorb tissue markers in any new patients, and to closely monitor those who have received the implants.
Lawsuits allege recalled BioZorb Markers failed to absorb after breast cancer treatments, resulting in painful complications and need for additional surgery.
Lawsuit comes days after FDA announced a BioZorb marker recall, indicating the implants are failing to properly be absorbed in women's bodies.
Black and Latina women were found to have an increased risk of developing breast cancer, potentially due to environmental factors, rather than genetic predispositions.
Manufacturer will remove all remaining BioZorb Markers from the market, following adverse events and lawsuits filed by women who experienced problems with the breast tissue implant.
Women experienced infections, scarring, device migration and other complications after a BioZorb marker failed to absorb properly, lawsuit claims.
Research supports earlier findings about the potential Mirena IUD breast cancer risks, as well as allegations presented in a previously filed class action lawsuit.
Earlier screening and improved breast cancer treatment options may mean more young women are being diagnosed and treated sooner.